Healthcare Sector

MRK

Market Tracker

$79.40
+1.28
(+1.64%)
2:40 am
Next Earnings: (est.) 08/01/23 12:00 am
  • MRK (Selected)

    Merck & Co., Inc.
  • MRK#

    Merck & Co., Inc. (MRK
  • MRKR

    Marker Therapeutics, Inc.

MRK Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

MRK Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

MRK Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

MRK Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

MRK Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

MRK Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
08/15/2025 CALL $83.00 2,415 +2,029 +525.65%
08/08/2025 CALL $80.00 1,904 +1,590 +506.37%
08/08/2025 CALL $82.00 1,787 +1,276 +249.71%
08/01/2025 PUT $77.00 2,975 +1,269 +74.38%
06/18/2026 PUT $70.00 6,066 +610 +11.18%
08/08/2025 PUT $77.00 807 +464 +135.28%
08/01/2025 PUT $79.00 629 -216 -25.56%
08/01/2025 CALL $82.00 4,044 -253 -5.89%
08/15/2025 CALL $95.00 26,684 -309 -1.14%
08/01/2025 PUT $83.00 802 -472 -37.05%
08/15/2025 PUT $90.00 843 -503 -37.37%
08/01/2025 PUT $84.00 529 -1,027 -66.00%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

MRK Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.04% 77.07M 8.28B
Vanguard 500 Index Fund 2.31% 58.61M 6.3B
Fidelity 500 Index Fund 1.09% 27.79M 2.99B
SPDR S&P 500 ETF Trust 1.08% 27.45M 2.95B
iShares Core S&P 500 ETF 0.89% 22.63M 2.43B
Vanguard Index-Value Index Fund 0.86% 21.91M 2.35B
Select Sector SPDR Fund-Health Care 0.81% 20.59M 2.21B
Vanguard Specialized-Health Care Fund 0.72% 18.31M 1.97B
Vanguard Institutional Index Fund-Institutional Index Fund 0.70% 17.77M 1.91B
Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF 0.68% 17.38M 1.87B

MRK News

  • Ascentage Pharma to Participate in Evercore China Biotech Summit

    08/01 08:00 am

    GlobeNewswire Inc.

    Read more
  • Drug Discovery Platforms Market Size Expected to Reach USD 635.45 Million by 2034

    07/30 10:00 am

    GlobeNewswire Inc.

    Read more
  • Merck Q2: EPS Beats, but Sales Flat as Vaccine Demand Slips Globally

    07/29 11:19 am

    Investing.com

    Read more
  • Therini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease

    07/29 08:00 am

    GlobeNewswire Inc.

    Read more
  • This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy?

    07/29 03:29 am

    The Motley Fool

    Read more
  • After Merck, Chinese Biotech Hengrui Pharma Collaborates With GSK In Worth $12 Billion Pact

    07/28 11:32 am

    Benzinga

    Read more
  • Oncology Drugs Market Insights, Competitive Landscape, and Forecast Report 2025-2032 | Immunotherapy Leads Growth in Oncology Market Due to Better Precision and Fewer Side Effects

    07/25 10:50 am

    GlobeNewswire Inc.

    Read more
  • Non-Hodgkin’s Lymphoma Market Forecast to Surge with Growing Adoption of Targeted and Cell-Based Therapies | DelveInsight

    07/24 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Should You Forget Pfizer and Buy This Magnificent Dividend Stock Instead?

    07/20 09:25 am

    The Motley Fool

    Read more
  • Could an Investment in SCHD Help Supplement Social Security Income in Retirement?

    07/19 04:11 pm

    The Motley Fool

    Read more
  • MERCK ALERT: Bragar Eagel & Squire, P.C. is Investigating Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

    07/19 02:54 pm

    GlobeNewswire Inc.

    Read more
  • European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

    07/18 11:30 am

    GlobeNewswire Inc.

    Read more
  • Orion-konsernin puolivuosikatsaus tammi–kesäkuu 2025

    07/18 05:00 am

    GlobeNewswire Inc.

    Read more
  • Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business

    07/17 08:15 am

    The Motley Fool

    Read more
  • Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA

    07/15 07:00 am

    GlobeNewswire Inc.

    Read more
  • Waldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements | DelveInsight

    07/14 01:00 pm

    GlobeNewswire Inc.

    Read more
  • AstraZeneca's Drug Shows Promise For Resistant Hypertension In Phase 3 Trial

    07/14 09:05 am

    Benzinga

    Read more
  • Epitopea renforce ses capacités de recherche et de développement clinique pour accélérer le passage à la clinique

    07/10 04:00 am

    GlobeNewswire Inc.

    Read more
  • Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic

    07/10 04:00 am

    GlobeNewswire Inc.

    Read more
  • Nvidia's $4 Trillion Milestone Lifts Wall Street: What's Moving Markets Wednesday?

    07/09 02:19 pm

    Benzinga

    Read more
  • Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug

    07/09 09:03 am

    Benzinga

    Read more
  • Sodium Perborate Market worth $184.0 million in 2030, at 3.7%, says MarketsandMarkets™

    07/04 04:00 am

    GlobeNewswire Inc.

    Read more
  • 3 Absurdly Cheap Stocks Ready for a Breakout

    06/28 10:09 am

    The Motley Fool

    Read more
  • RFK Jr's CDC Panel Recommends Merck's RSV Shot For Infants

    06/27 07:56 am

    Benzinga

    Read more
  • Medicenna Therapeutics Reports Fiscal Year 2025 Financial Results and Operational Highlights

    06/26 07:00 am

    GlobeNewswire Inc.

    Read more
  • 2 Dividend Stocks to Buy and Never Sell

    06/18 05:02 am

    The Motley Fool

    Read more
  • These Were the 2 Worst-Performing Stocks in the Dow Jones Industrial Average in May 2025

    06/14 08:02 am

    The Motley Fool

    Read more
  • Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery

    06/13 02:08 pm

    Benzinga

    Read more
  • Why Summit Therapeutics Stock Tanked Today

    06/11 05:28 pm

    The Motley Fool

    Read more
  • Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors

    05/27 09:00 am

    GlobeNewswire Inc.

    Read more
  • MRK Down 21% YTD: Should You Buy, Hold or Sell the Stock?

    05/26 11:01 am

    Zacks Investment Research

    Read more
  • 3 Deep-Value Stocks to Buy as Bulls Take a Breather

    05/22 10:16 am

    Investing.com

    Read more
  • Moderna Stock Looks Ripe for a Short Squeeze

    05/22 08:21 am

    Investing.com

    Read more
  • Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01

    05/22 08:00 am

    GlobeNewswire Inc.

    Read more
  • Bio/Pharmaceutical Outsourcing Report, March 2025 Edition - Trump Tariffs Drive Pharma Manufacturing to US but Risk Inflation and Disruption

    05/19 10:56 am

    GlobeNewswire Inc.

    Read more
  • Neurofibromatosis Type 1 Market Set to Witness Significant Growth During the Study Period (2020–2034) Driven by Advances in Treatment | DelveInsight

    05/15 01:00 pm

    GlobeNewswire Inc.

    Read more
  • 3 Absurdly Cheap Stocks Trading Near Their 52-Week Lows

    05/14 11:31 am

    The Motley Fool

    Read more
  • TILT Biotherapeutics Announces Closing of USD 25 Million Series B Financing

    05/13 03:00 am

    GlobeNewswire Inc.

    Read more
  • Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight

    05/12 01:00 pm

    GlobeNewswire Inc.

    Read more
  • 2 Beaten-Down Stocks That Are Great Buys on the Dip

    05/08 09:12 am

    The Motley Fool

    Read more
  • Can Summit Therapeutics Stock Double Your Money?

    05/07 09:30 am

    The Motley Fool

    Read more
  • Multiple System Atrophy (MSA) Market Research 2025-2035 - Emerging Alpha-Synuclein Therapies and Strategic Pharma Collaborations Propel MSA Market Towards Disease-Modifying Breakthroughs

    05/07 04:41 am

    GlobeNewswire Inc.

    Read more
  • Liver Cancer Treatment Market is expected to generate a revenue of USD 8.88 Billion by 2031, Globally, at 13.45% CAGR: Verified Market Research®

    05/02 10:00 am

    GlobeNewswire Inc.

    Read more
  • This Soaring Stock Just Delivered More Good News. Time to Buy?

    05/02 08:30 am

    The Motley Fool

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: